Dualistic actions of cromakalim and new potent 2H-1,4-benzoxazine derivatives on the native skeletal muscle K ATP channel

British Journal of Pharmacology

Volumn 139, Issue 2, 2003, Pages 255-262

  Tricarico, Domenico ^a   Barbieri, Mariagrazia ^a   Antonio, Laghezza ^a   Tortorella, Paolo ^a   Loiodice, Fulvio ^a   Conte Camerino, Diana ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

2H 1,4 benzoxazine; Cromakalim; K ATP channel; KCO; Patch clamp; Skeletal muscle

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALKYL GROUP; BENZOXAZINE DERIVATIVE; CROMAKALIM; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT;

ANIMAL TISSUE; ARTICLE; BINDING SITE; DOSE RESPONSE; DRUG BINDING; DRUG MECHANISM; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; MALE; NONHUMAN; PATCH CLAMP; PHARMACOPHORE; POTASSIUM CURRENT; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ADENOSINE TRIPHOSPHATE; ANIMALS; BINDING SITES; CROMAKALIM; MALE; MUSCLE, SKELETAL; OXAZINES; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNELS; RATS; RATS, WISTAR; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0038267944     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705233     Document Type: Article

References (32)

1. ADLAR, M., OKAFO, G., MEENAN, E. & CAMILLERI P. (1995). Rapid estimation of octanol - water partition coefficients using deoxycholate micelles in capillary electrophoresis. J. Chem. Soc. Chem. Commun., No. 21, 2241-2243.
2. ALLARD, B. & LAZDUNSKI, M. (1992). Nucleotides diphosphates activate the ATP-sensitive potassium channels in mouse skeletal muscle. Pflugers Arch., 422, 185-192.
3. ANDERSSON, K.E. (1992). Clinical pharmacology of potassium channel openers. Pharmacol. Toxicol., 70, 244-254.
4. ATP channel openers. TiPS, 21, 439-445.
5. BABENKO, A.P., GONZALES, G. & BRYAN, J. (2000). Pharmacotopology of sulfonylurea receptors. J. Biol. Chem., 275, 717-720.
6. BETTONI, G., FERRORELLI, S., LOIODICE, F., TANGARI, N., TORTORELLA, V., GASPARRINI, F., MISITI, D. & VILLANI, C. (1992). Chiral α-substituted α-aryloxy acetic acids: synthesis, absolute configuration, chemical resolution and direct separation by HPLC. Chirality, 4, 193-203.
7. BETTONI, G., LOIODICE, F., TORTORELLA, V., CONTE-CAMERINO, D., MAMBRINI, M., FERRANINI, E. & BRYANT, S.H. (1987). Stereospecificity of the chloride ion channel: the action of chiral clofibric acid analogues. J. Med. Chem., 30, 1267-1270.
8. CALIENDO, G., GRIECO, P., PERISSUTTI, E., SANTAGATA, V., SANTINI, A., ALBRIZIO, S., FATTORUSSO, C., PINTO, A. & SORRENTINO, R. (1998). Synthesis, biological activity and conformational study of 1,4-benzoxazine derivatives as potassium channel modulators. Eur. J. Med. Chem., 33, 957-967.
9. + channel openers. Mol. Pharmacol., 56, 308-315.
10. DICKINSON, K.E.J., BRYSON, C.C., COHEN, R.B., ROGERS, L., GREEN, D.W. & ATWAL, K.S. (1997). Nucleotide regulation and characteristics of potassium channel opener binding to skeletal muscle membranes. Mol. Pharmacol., 52, 473-481.
11. FORESTIER, C., PIERRARD, J. & VIVAUDOU, M. (1996). Mechanism of action of K channel openers on skeletal muscle KATP channels. Interactions with nucleotides and protons. J. Gen. Physiol., 107, 489-502.
12. FRYER, R.I., EARLEY, J.V., FIELD, G.F., ZALLY, W. & STERNBACH, L.H. (1969). A synthesis of amidines from cyclic amides. J. Org. Chem., 34, 1143-1145.
13. + channel openers. TiPS, 15, 402.
14. ATP channels in mouse skeletal muscle in the presence of different nucleotides. Cardiovasc. Res., 28, 841-846.
15. ATP channels by Na/K pump in isolated cardiac myocytes and giant membrane patches. Biophys. J., 75, 2858-2867.
16. + channel openers by pharmacophore model. Bioorg. Med. Chem. Lett., 3, 625-631.
17. ATP) in isolated cat ventricular myocytes. Eur. J. Pharmacol., 383, 197-202.
18. LAWSON, K. (2000). Potassium channel openers as potential therapeutic weapons in ion channel disease. Kidney Int., 57, 838-845.
19. LONGMAN, S.D. & HAMILTON, T.C. (1992). Potassium channel activator drugs: mechanism of action, pharmacological properties, and therapeutic potential. Med. Res., Rev., 12, 73-148.
20. 1). Synthesis and pharmacological evaluation of 3,4-dihydro-2H-1,4-benzoxazine derivatives: modification of the aromatic part. Chem. Pharm. Bull., 47, 971-979.
21. MATSUMOTO, Y., TSUZUKI, R., MATSUHISA, A., TAKANAMA, K., YODEN, T., UCHIDA, W., ASANO, M., FUJITA, S., YANAGISAWA, I. & FUJIKURA, T. (1996). Novel potassium channel activators: synthesis and structure - activity relationship studies of 3,4-dihydro-2H-1, 4-benzoxazine derivatives. Chem. Pharm. Bull., 44, 103-114.
22. MATSUMOTO, Y., UCHIDA, A., NAKAHARA, H., YANAGISAWA, I., SHIBANUMA, T. & NOHIRA, H. (2000). Novel potassium channel activators. III. Synthesis and pharmacological evaluation of 3,4-dihydro-2H-1,4-benzoxazine derivatives: modification at the position 2. Chem. Pharm. Bull., 48, 428-432.
23. ATP channel openers. EMBO J., 19, 6644-6651.
24. + channel openers suppress myotonic activity of human skeletal muscle in vitro. Eur. J. Pharmacol., 186, 125-128.
25. ROVATI, E.G. & NICOSIA, S. (1994). Lower efficacy: interaction with an inhibitory receptor or partial agonism? TiPS, 15, 141-144.
26. SCHWANSTECHER, M., SIEVERDING, C., DORSCHNER, H., GROSS, I., AGUILAR-BRYAN, L., SCHWANSTECHER, C. & BRYAN, J. (1998). Potassium channel openers require ATP to bind to and act through sulfonylurea receptorS. EMBO J., 17, 5529.
27. SEEBOHM, G., LERCHE, C., PUSCH, M., STEINMEYER, K., BRUGGEMANN, A. & BUSCH, A.E. (2001). A kinetic study on the stereospecific inhibition of KCNQ1 and Iks by the chromanol 293B. Br. J. Pharmacol., 134, 1647-1654.
28. SONG, D.K. & ASHCROFT, F.M. (2001). ATP-modulation of K(sub-ATP) channel ATP-sensitivity varies with the type of SUR subunit. J. Biol. Chem., 276, 7143-7149.
29. TERAMOTO, N., YUNOKI, T., TAKANO, M., YONEMITSU, Y., MASAKI, I., SUEISHI, K., BRADING, A.F. & ITO, Y. (2001). Dual action of ZD6169, a novel K(+) channel opener, on ATP-sensitive K(+) channels in pig urethral myocytes. Br. J. Pharmacol., 133, 154-164.
30. + depleted rats, an animal model of hypokalemic periodic paralysis. Mol. Pharmacol., 54, 197-206.
31. + channels in patients with hypokalemic periodic paralysis. J. Clin. Invest., 103, 675-682.
32. UHDE, I., TOMAN, A., GROSS, I., SCHWANSTECHER, C. & SCHWANSTECHER, M. (1999). Identification of the potassium channel opener site on sulfonylurea receptors. J. Biol. Chem., 274, 28079-28082.